Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Nanobodies for Theranostic Positron Emission Tomography (PET) Imaging and Radioimmunotherapy of Head and Neck Cancer

EF 2025-26

Résumé
Head and neck cancer refers to cancers in the mouth and throat. It is the 6th most common cancer worldwide, with nearly 1 million new cases and 500,000 deaths each year. Yet, current imaging and treatment options have limitations that can lead to late diagnoses, recurrence, and metastasis (spread to other areas of the body), which negatively affect patient outcomes. Therefore, new methods must be developed. One approach involves targeting proteins that are overexpressed on cancer cells compared to healthy cells. Targeting agents, such as antibodies, can be attached to a radioisotope for nuclear medicine imaging or to treat tumours with radiation. However, the large size of antibodies poses challenges of slow tumour penetration and prolonged circulation times, which could interfere with imaging and increase toxicity to healthy tissue. Thus, we are interested in exploring smaller engineered antibody fragments called nanobodies, which are about one-tenth the size of antibodies but retain the same specificity, offering properties that may overcome these issues. Our goal is to link head and neck cancer-specific nanobodies to radioisotopes as agents for both imaging and treatment. These radiolabelled nanobodies can then be studied in mice that are implanted with head and neck cancer patient-derived tumours. These mouse tumour models capture the properties of the tumours in patients and are therefore the most predictive of whether or not the approach we are studying may be successful in patients. Ultimately, this research could lead to new ways to image and treat head and neck cancer that hopefully will improve patient outcomes.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572582
Name
Lee Caitlyn M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Nanobodies for Theranostic Positron Emission Tomography (PET) Imaging and Radioimmunotherapy of Head and Neck Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Antibodies; Copper-64; Head And Neck Squamous Cell Carcinoma (Hnscc); Lutetium-177; Nanobodies; Patient-Derived Xenografts (Pdx); Positron Emission Tomography (Pet) Imaging; Radioimmunotherapy; Theranostics
Abstract
Head and neck cancer refers to cancers in the mouth and throat. It is the 6th most common cancer worldwide, with nearly 1 million new cases and 500,000 deaths each year. Yet, current imaging and treatment options have limitations that can lead to late diagnoses, recurrence, and metastasis (spread to other areas of the body), which negatively affect patient outcomes. Therefore, new methods must be developed. One approach involves targeting proteins that are overexpressed on cancer cells compared to healthy cells. Targeting agents, such as antibodies, can be attached to a radioisotope for nuclear medicine imaging or to treat tumours with radiation. However, the large size of antibodies poses challenges of slow tumour penetration and prolonged circulation times, which could interfere with imaging and increase toxicity to healthy tissue. Thus, we are interested in exploring smaller engineered antibody fragments called nanobodies, which are about one-tenth the size of antibodies but retain the same specificity, offering properties that may overcome these issues. Our goal is to link head and neck cancer-specific nanobodies to radioisotopes as agents for both imaging and treatment. These radiolabelled nanobodies can then be studied in mice that are implanted with head and neck cancer patient-derived tumours. These mouse tumour models capture the properties of the tumours in patients and are therefore the most predictive of whether or not the approach we are studying may be successful in patients. Ultimately, this research could lead to new ways to image and treat head and neck cancer that hopefully will improve patient outcomes.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Caitlyn M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~